Literature DB >> 16317341

Selective sensitivity of Caenorhabditis elegans neurons to RNA interference.

Suvi Asikainen1, Suvi Vartiainen, Merja Lakso, Richard Nass, Garry Wong.   

Abstract

RNA interference is a new approach to knockdown gene expression, but effectiveness varies depending on the organism, cell type or target sequence. Studies with Caenorhabditis elegans have shown that subsets of cells including neurons are often resistant to RNA interference. We measured RNA interference using green fluorescent protein reporter strains and feeding, soaking and injection delivery methods in a number of Caenorhabditis elegans neuron subtypes (dopaminergic, GABAergic, cholinergic, glutamatergic, touch). The sensitivity to RNA interference varied: GABAergic and dopaminergic neurons showed greater resistance while cholinergic, glutamatergic and touch neurons were more sensitive. Dysfunctional RRF-3, a putative RNA-directed RNA polymerase, had a significant effect on increasing neuron sensitivity in most subtypes. These results demonstrate that Caenorhabditis elegans neurons vary in their sensitivity to RNA interference.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16317341     DOI: 10.1097/00001756-200512190-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  26 in total

1.  Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.

Authors:  Marija Usenovic; Adam L Knight; Arpita Ray; Victoria Wong; Kevin R Brown; Guy A Caldwell; Kim A Caldwell; Igor Stagljar; Dimitri Krainc
Journal:  Hum Mol Genet       Date:  2012-05-29       Impact factor: 6.150

Review 2.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

Review 3.  Antimicrobial effectors in the nematode Caenorhabditis elegans: an outgroup to the Arthropoda.

Authors:  Katja Dierking; Wentao Yang; Hinrich Schulenburg
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-05-26       Impact factor: 6.237

4.  Repurposing an endogenous degradation system for rapid and targeted depletion of C. elegans proteins.

Authors:  Stephen T Armenti; Lauren L Lohmer; David R Sherwood; Jeremy Nance
Journal:  Development       Date:  2014-11-05       Impact factor: 6.868

5.  FSHR-1/GPCR Regulates the Mitochondrial Unfolded Protein Response in Caenorhabditis elegans.

Authors:  Sungjin Kim; Derek Sieburth
Journal:  Genetics       Date:  2019-12-04       Impact factor: 4.562

6.  Regulation of intracellular heme trafficking revealed by subcellular reporters.

Authors:  Xiaojing Yuan; Nicole Rietzschel; Hanna Kwon; Ana Beatriz Walter Nuno; David A Hanna; John D Phillips; Emma L Raven; Amit R Reddi; Iqbal Hamza
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-15       Impact factor: 11.205

7.  Characterization of the effects of methylmercury on Caenorhabditis elegans.

Authors:  Kirsten J Helmcke; Tore Syversen; David M Miller; Michael Aschner
Journal:  Toxicol Appl Pharmacol       Date:  2009-03-31       Impact factor: 4.219

8.  Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model.

Authors:  Shusei Hamamichi; Renee N Rivas; Adam L Knight; Songsong Cao; Kim A Caldwell; Guy A Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2008-01-08       Impact factor: 11.205

9.  Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci.

Authors:  Weston B Struwe; Bethany L Hughes; David W Osborn; Erica D Boudreau; Kristin M D Shaw; Charles E Warren
Journal:  Glycobiology       Date:  2009-09-03       Impact factor: 4.313

10.  Syndecan promotes axon regeneration by stabilizing growth cone migration.

Authors:  Tyson J Edwards; Marc Hammarlund
Journal:  Cell Rep       Date:  2014-07-04       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.